» Articles » PMID: 10684276

Immune Responses Following Neonatal DNA Vaccination Are Long-lived, Abundant, and Qualitatively Similar to Those Induced by Conventional Immunization

Overview
Journal J Virol
Date 2000 Feb 23
PMID 10684276
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Virus infections are devastating to neonates, and the induction of active antiviral immunity in this age group is an important goal. Here, we show that a single neonatal DNA vaccination induces cellular and humoral immune responses which are maintained for a significant part of the animal's life span. We employ a sensitive technique which permits the first demonstration and quantitation, directly ex vivo, of virus-specific CD8(+) T cells induced by DNA immunization. One year postvaccination, antigen-specific CD8(+) T cells were readily detectable and constituted 0.5 to 1% of all CD8(+) T cells. By several criteria-including cytokine production, perforin content, development of lytic ability, and protective capacity-DNA vaccine-induced CD8(+) memory T cells were indistinguishable from memory cells induced by immunization with a conventional (live-virus) vaccine. Analyses of long-term humoral immune responses revealed that, in contrast to the strong immunoglobulin G2a (IgG2a) skewing of the humoral response seen after conventional vaccination, IgG1 and IgG2a levels were similar in DNA-vaccinated neonatal and adult animals, indicating a balanced T helper response. Collectively, these results show that a single DNA vaccination within hours or days of birth can induce long-lasting CD8(+) T- and B-cell responses; there is no need for secondary immunization (boosting). Furthermore, the observed immune responses induced in neonates and in adults are indistinguishable by several criteria, including protection against virus challenge.

Citing Articles

LAMP-1 Chimeric to HIV-1 p55Gag in the Immunization of Neonate Mice Induces an Early Germinal Center Formation and AID Expression.

Emidio Teixeira F, Oliveira L, Pietrobon A, de Salles E, DImperio Lima M, Viana I Vaccines (Basel). 2022; 10(8).

PMID: 36016134 PMC: 9414238. DOI: 10.3390/vaccines10081246.


Sphingosine kinase 2 restricts T cell immunopathology but permits viral persistence.

Studstill C, Pritzl C, Seo Y, Kim D, Xia C, Wolf J J Clin Invest. 2020; 130(12):6523-6538.

PMID: 32897877 PMC: 7685747. DOI: 10.1172/JCI125297.


Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency.

Farrag M, Amer H, Ohlschlager P, Hamad M, Almajhdi F Hum Vaccin Immunother. 2017; 13(7):1586-1597.

PMID: 28272978 PMC: 5512761. DOI: 10.1080/21645515.2017.1295190.


Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.

Dai G, Rady H, Huang W, Shellito J, Mason C, Ramsay A Vaccine. 2016; 34(50):6267-6275.

PMID: 27823900 PMC: 5131305. DOI: 10.1016/j.vaccine.2016.10.065.


A ceramide analogue stimulates dendritic cells to promote T cell responses upon virus infections.

Pritzl C, Seo Y, Xia C, Vijayan M, Stokes Z, Hahm B J Immunol. 2015; 194(9):4339-49.

PMID: 25810392 PMC: 4402267. DOI: 10.4049/jimmunol.1402672.


References
1.
Mor G, Yamshchikov G, Sedegah M, Takeno M, Wang R, Houghten R . Induction of neonatal tolerance by plasmid DNA vaccination of mice. J Clin Invest. 1996; 98(12):2700-5. PMC: 507733. DOI: 10.1172/JCI119094. View

2.
Barrios C, Brawand P, Berney M, Brandt C, Lambert P, Siegrist C . Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur J Immunol. 1996; 26(7):1489-96. DOI: 10.1002/eji.1830260713. View

3.
Slifka M, Rodriguez F, Whitton J . Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells. Nature. 1999; 401(6748):76-9. DOI: 10.1038/43454. View

4.
Bachmann M, Barner M, Viola A, Kopf M . Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection. Eur J Immunol. 1999; 29(1):291-9. DOI: 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO;2-K. View

5.
Larsen P, Chartrand S, Tomashek K, Hauser L, Ksiazek T . Hydrocephalus complicating lymphocytic choriomeningitis virus infection. Pediatr Infect Dis J. 1993; 12(6):528-31. DOI: 10.1097/00006454-199306000-00013. View